FMC Business Summary

FMC Corporation is a pure-play agricultural sciences company that generates revenue through the development and sale of proprietary crop protection technologies, including insecticides, herbicides, and fungicides. The company’s business model is centered on a high-density R&D pipeline that commercializes patented active ingredients, most notably its diamide franchise featuring Rynaxypyr and Cyazypyr. Revenue is primarily derived from direct product sales to growers and distributors, supplemented by licensing agreements for its proprietary chemistry. As of February 2026, FMC is executing a "post-patent" strategy to maintain market share amid generic competition for its blockbuster products while expanding its Plant Health segment through biologicals and pheromones. Its primary global competitors include Corteva, Bayer, BASF, and Syngenta; FMC maintains a top-five global position in the patented crop protection market, though it is currently exploring strategic alternatives, including a potential sale of the company, to optimize shareholder value. The leadership team is led by Pierre R. Brondeau, who serves as Chairman, CEO, and President after returning to the chief executive role in 2024 and assuming the presidency in late 2025. Brondeau brings extensive industry pedigree from his previous decade-long tenure as FMC’s CEO and his prior role as CEO of Dow’s Advanced Materials Division. Key executives include Executive Vice President and CTO Seva Rostovtsev, who oversees a global network of over 800 scientists, and CFO Andrew D. Sandifer, who is currently managing a $1 billion debt reduction initiative. While the company was founded in 1883 by John Bean as a spray pump manufacturer, the modern executive team has transitioned the firm into a specialized chemical innovator. The company’s strategic direction is supported by a board featuring Lead Independent Director C. Scott Greer and notable institutional backing from major shareholders such as The Vanguard Group and D.E. Shaw & Co.